Jaw Abnormalities: Clinical Trials

11 trials for Jaw Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 1 recruiting. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 7, Unknown 3, Recruiting 1
Phase 22Completed 1, Unknown 1

Follow Jaw Abnormalities: new trials by email Literature Review of Jaw Abnormalities trials Research Report on Jaw Abnormalities

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liposomal Bupivacaine Use in Alveolar Bone Graft Patients
Liposomal Bupivacaine, Bupivacain, Epinephrine - Cleft Lip and Palate
Phase 3UnknownKerry O'Rourke602024-04-242024-07-03
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
Orthognathic Surgery, Melatonin 10 MG Oral Tablet, Hydroxycobalamin - Retrognathism, Prognathism
Phase 2 / Phase 3UnknownUniversitat Internacional de Catalunya2202022-09-302022-09-13
A Single Bolus of Dexmedetomidine Versus Normal Saline in Postoperative Agitation
Dexmedetomidine, 0.9% saline - Cleft Palate
Phase 3CompletedAssiut University602021-06-202026-05-07
Nebulized Bupivacaine Analgesia for Cleft Palate Repair
Bupivacaine Hydrochloride, 0.9% saline - Cleft Palate
Phase 3RecruitingAssiut University602021-06-142026-09-09
Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery
Tranexamic Acid, saline solution - Peri-operative Hemorrhage or Hematoma, Surgery
Phase 3CompletedUniversity Hospital, Lille1572016-01-032026-04-22
Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery
Levobupivacaine, Bupivacaine - Recovery After Cleft Palate Surgery
Phase 2 / Phase 3CompletedAssiut University602016-01-012017-09-07
Comparative Results of Maxillary Deficiency Treatment by Fixed Tongue Appliance and Fixed Facemask in Growing Patients
Fixed Tongue Appliance, Fixed Face Mask - Maxillary Deficiency
Phase 3UnknownShahid Beheshti University202009-06-012010-07-27
Comparative Results of Maxillary Deficiency Treatment by Tongue Plate and Facemask in Growing Patients
Tongue plate, Facemask - Maxillary Deficiency
Phase 3CompletedShahid Beheshti University of Medical Sciences202007-09-012008-12-19
Oral Cleft Prevention Program
Folic acid: 4 mg versus 0.4 mg per day - Cleft Lip, Cleft Palate
Phase 3CompletedUniversity of Iowa40002006-11-012017-03-31
A Comparison of Bupivacaine and Ketorolac for Postoperative Analgesia After Iliac Crest Bone Harvesting
Ketorolac, Bupivacaine, ketorolac + bupivacaine - Postoperative Pain
Phase 3CompletedThe Hospital for Sick Children542006-05-012013-08-20
Oral Cleft Prevention Trial in Brazil
Folic acid (0.4mg vs. 4.0mg) - Cleft Lip, Cleft Palate
Phase 3CompletedNICHD Global Network for Women's and Children's Health22002004-01-012013-12-17

Narrower conditions

Cleft Palate (7)  ·  Retrognathia (4)  ·  Cleft Lip (3)  ·  Agnosia (1)  ·  Congenital Abnormalities (1)  ·  Hematoma (1)  ·  Pain, Postoperative (1)  ·  Prognathism (1)  ·  Sensation Disorders (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11)  ·  Craniofacial Abnormalities (11)  ·  Jaw Diseases (11)  ·  Maxillofacial Abnormalities (11)  ·  Musculoskeletal Abnormalities (11)  ·  Musculoskeletal Diseases (11)  ·  Stomatognathic Diseases (11)  ·  Stomatognathic System Abnormalities (11)  ·  Congenital Abnormalities (10)  ·  Mouth Abnormalities (7)  ·  Mouth Diseases (7)  ·  Mandibular Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Lip Diseases (3)

Interventions

Bupivacaine (4)  ·  Saline Solution (3)  ·  Folic Acid (2)  ·  Cytidine (1)  ·  Dexmedetomidine (1)  ·  Epinephrine (1)  ·  Hydroxocobalamin (1)  ·  Ketorolac (1)  ·  Levobupivacaine (1)  ·  Masks (1)  ·  Melatonin (1)  ·  Orthognathic Surgery (1)  ·  Tablets (1)  ·  Tranexamic Acid (1)  ·  Uridine (1)

Sponsors

Assiut University (3)  ·  Kerry O'Rourke (1)  ·  NICHD Global Network for Women's and Children's Health (1)  ·  Shahid Beheshti University (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  The Hospital for Sick Children (1)  ·  Universitat Internacional de Catalunya (1)  ·  University Hospital, Lille (1)  ·  University of Iowa (1)

Countries

Egypt (3)  ·  Iran (2)  ·  United States (2)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)

Top investigators

Chad A. Purnell, MD (1)  ·  Elsa Jozefowicz, MD (1)  ·  Jason Hayes, MD (1)  ·  Jeff Murray, M.D. (1)  ·  Jeffrey Murray, MD (1)  ·  Lida Toomarian (1)  ·  Mahkameh Mirkarimi (1)  ·  Mohammad Behnaz (1)  ·  Omar Soliman (1)  ·  Omar Soliman, MD (1)  ·  Pedro Sole, DMD, OMFS (1)  ·  Rahman Showkatbakhsh (1)  ·  Rahman Showkatbakhsh, Professor (1)

Results publications

PMID 19854614, PMID 21091369, PMID 23181832, PMID 23669628, PMID 24525630, PMID 34465477

NIH funding

2015 (1), U01DE017958 (1)